2020
DOI: 10.1016/j.crad.2019.11.014
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac MRI for the evaluation of cardiac neoplasms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
13
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 23 publications
0
13
0
1
Order By: Relevance
“… 14 An MRI can also differentiate between thrombus and metastasis: whereas thrombus is avascular and does not show contrast enhancement, metastasis will show enhancement in both first-pass perfusion imaging and late gadolinium enhanced T1-weighted images. 14 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… 14 An MRI can also differentiate between thrombus and metastasis: whereas thrombus is avascular and does not show contrast enhancement, metastasis will show enhancement in both first-pass perfusion imaging and late gadolinium enhanced T1-weighted images. 14 …”
Section: Discussionmentioning
confidence: 99%
“…13 On cardiovascular MRI, metastases are typically T1 hypointense and heterogeneously T2 hyperintense; however, melanoma is an exception and is typically T1 hyperintense due to the presence of melanin. 14 An MRI can also differentiate between thrombus and metastasis: whereas thrombus is avascular and does not show contrast enhancement, metastasis will show enhancement in both first-pass perfusion imaging and late gadolinium enhanced T1-weighted images. 14 Prognosis of metastatic melanoma used to be extremely poor, with a 5-year overall survival of 10%.…”
Section: Discussionmentioning
confidence: 99%
“…Las secuencias de perfusión permiten evaluar la vascularización tumoral. Finalmente, con el realce tardío se completa la caracte rización tisular, que dado la heterogeneidad en este contexto, nos marca la malignidad lesional (4) .…”
Section: Discussionunclassified
“…CMR can be considered the gold standard for assessment of non-thrombotic masses (82). In stroke patients particularly, CMR is useful for differentiating tumors from thrombi (83).…”
Section: Yield Of Cmr and Echocardiography For Specific Pathologiesmentioning
confidence: 99%